Clinical Autonomic Research

, Volume 24, Issue 2, pp 77–85 | Cite as

Relationship of muscle sympathetic nerve activity to insulin sensitivity

  • Timothy B. Curry
  • Casey N. Hines
  • Jill N. Barnes
  • Madhuri Somaraju
  • Rita Basu
  • John M. Miles
  • Michael J. Joyner
  • Nisha Charkoudian
Research Article
First Online:
Received:
Accepted:

Abstract

Purpose

An association between insulin resistance and activation of the sympathetic nervous system has been reported in previous studies. However, potential interactions between insulin sensitivity and sympathetic neural mechanisms in healthy people remain poorly understood. We conducted a study to determine the relationship between sympathetic activity and insulin resistance in young, healthy humans.

Methods

Thirty-seven healthy adults (18–35 years, BMI <28 kg m−2) were studied. Resting muscle sympathetic nerve activity (MSNA) was measured with microneurography and insulin sensitivity of glucose and free fatty acid metabolism was measured during a hyperinsulinemic-euglycemic clamp with two levels of insulin.

Results

During lower doses of insulin, we found a small association between lower insulin sensitivity and higher MSNA (P < 0.05) but age was a cofactor in this relationship. Overall, we found no difference in insulin sensitivity between groups of low and high MSNA, but when women were analyzed separately, insulin sensitivity was lower in the high MSNA group compared with the low MSNA group of women.

Conclusions

These data suggest that MSNA and insulin sensitivity are only weakly associated with young healthy individuals and that age and sex may be important modifiers of this relationship.

Keywords

Sympathetic nervous system Insulin resistance Glucose clamp technique Body composition 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

Special thanks to D. Schroder of Mayo Clinic Biomedical Statistics and Informatics for support in designing studies and statistical analysis. We also thank S. Roberts, S. Wolhart, K. Edens, C. Johnson, L. Matzek, J. Taylor, B. Walker, P. Engrav, N. Meyer, and D. Vlazny of Mayo Clinic for their assistance in conducting the studies. The project was supported by the Mayo Foundation for Medical Education and Research and NIH Grant Numbers ULRR24150, UL1TR000135, R01DK50456, K23DK82424, T32AR056950, F32AG 38067, R01DK90541, R01HL67933, R01HL83947. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of Mayo Foundation or the NIH.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

References

  1. 1.
    Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438–2446PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB, Wallin BG (2006) Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572:821–827PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Curry TB, Roberts SK, Basu R, Basu A, Schroeder D, Joyner MJ, Miles JM (2011) Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab 300:E746–E751PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Facchini FS, Stoohs RA, Reaven GM (1996) Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9:1013–1017PubMedCrossRefGoogle Scholar
  5. 5.
    Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008) Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 57:1422–1427PubMedCrossRefGoogle Scholar
  6. 6.
    Flanagan DE, Vaile JC, Petley GW, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI (1999) The autonomic control of heart rate and insulin resistance in young adults. J Clin Endocr Metab 84:1263–1267PubMedGoogle Scholar
  7. 7.
    Florian JP, Pawelczyk JA (2009) Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci (Colch) 118:61–69CrossRefGoogle Scholar
  8. 8.
    Geer EB, Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6(Suppl 1):60–75PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Grassi G, Dell’Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G (2005) Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48:1359–1365PubMedCrossRefGoogle Scholar
  10. 10.
    Grassi G, Seravalle G, Quarti-Trevano F, Mineo C, Lonati L, Facchetti R, Mancia G (2010) Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea. J Hypertens 28:1313–1320PubMedGoogle Scholar
  11. 11.
    Gudbjornsdottir S, Friberg P, Elam M, Attvall S, Lonnroth P, Wallin BG (1994) The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Press 3:394–403PubMedCrossRefGoogle Scholar
  12. 12.
    Henry S, Trueb L, Sartori C, Scherrer U, Jequier E, Tappy L (1998) Effects of a sympathetic activation by a lower body negative pressure on glucose and lipid metabolism. Clin Physiol 18:562–569PubMedCrossRefGoogle Scholar
  13. 13.
    Huggett RJ, Burns J, Mackintosh AF, Mary DA (2004) Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44:847–852PubMedCrossRefGoogle Scholar
  14. 14.
    Huggett RJ, Hogarth AJ, Mackintosh AF, Mary DA (2006) Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia 49:2741–2744PubMedCrossRefGoogle Scholar
  15. 15.
    Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA (2003) Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 108:3097–3101PubMedCrossRefGoogle Scholar
  16. 16.
    Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO (1993) Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21:618–623PubMedCrossRefGoogle Scholar
  17. 17.
    Jensen MD, Kanaley JA, Reed JE, Sheedy PF (1995) Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr 61:274–278PubMedGoogle Scholar
  18. 18.
    Jones PP, Snitker S, Skinner JS, Ravussin E (1996) Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol 270:E363–E366PubMedGoogle Scholar
  19. 19.
    Julius S, Jamerson K (1994) Sympathetics, insulin resistance and coronary risk in hypertension: the ‘chicken-and-egg’ question. J Hypertens 12:495–502PubMedCrossRefGoogle Scholar
  20. 20.
    Khoury N, McGill JB (2011) Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine. Diabetes Metab Res Rev 27:604–608PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Kienbaum P, Karlssonn T, Sverrisdottir YB, Elam M, Wallin BG (2001) Two sites for modulation of human sympathetic activity by arterial baroreceptors? J Physiol (Lond) 531:861–869CrossRefGoogle Scholar
  22. 22.
    Klein S (2004) The case of visceral fat: argument for the defense. J Clin Invest 113:1530–1532PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP (2010) Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications. Pharmacol Ther 126:159–172PubMedCrossRefGoogle Scholar
  24. 24.
    Masuo K, Mikami H, Ogihara T, Tuck ML (1997) Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 10:77–83PubMedCrossRefGoogle Scholar
  25. 25.
    McCarty MF (2004) Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes. Med Hypotheses 62:830–838PubMedCrossRefGoogle Scholar
  26. 26.
    Miles JM, Ellman MG, McClean KL, Jensen MD (1987) Validation of a new method for determination of free fatty acid turnover. Am J Physiol 252:E431–E438PubMedGoogle Scholar
  27. 27.
    Miles JM, Nelson RH (2007) Lipid kinetics. In: Roden M (ed) Clinical diabetes research: methods and techniques. Wiley, Chichester, pp 151–168CrossRefGoogle Scholar
  28. 28.
    Minson CT, Halliwill JR, Young TM, Joyner MJ (2000) Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101:862–868PubMedCrossRefGoogle Scholar
  29. 29.
    Muntzel MS, Anderson EA, Johnson AK, Mark AL (1995) Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 17:39–50PubMedCrossRefGoogle Scholar
  30. 30.
    Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M, Palatini P, Sivitz WI, Somers VK (2001) Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 19:1089–1094PubMedCrossRefGoogle Scholar
  31. 31.
    Narkiewicz K, Winnicki M, Schroeder K, Phillips BG, Kato M, Cwalina E, Somers VK (2002) Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension 39:168–172PubMedCrossRefGoogle Scholar
  32. 32.
    Ng AV, Callister R, Johnson DG, Seals DR (1993) Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21:498–503PubMedCrossRefGoogle Scholar
  33. 33.
    Nielsen S, Halliwill JR, Joyner MJ, Jensen MD (2004) Vascular response to angiotensin II in upper body obesity. Hypertension 44:435–441PubMedCrossRefGoogle Scholar
  34. 34.
    Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P (1994) Body fat and sympathetic nerve activity in healthy subjects. Circulation 89:2634–2640PubMedCrossRefGoogle Scholar
  35. 35.
    Shadid S, Kanaley JA, Sheehan MT, Jensen MD (2007) Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab 292:E1770–E1774PubMedCrossRefGoogle Scholar
  36. 36.
    Straznicky NE, Eikelis N, Lambert EA, Esler MD (2008) Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 10:440–447PubMedCrossRefGoogle Scholar
  37. 37.
    Sundlof G, Wallin BG (1978) Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol (Lond) 274:621–637Google Scholar
  38. 38.
    Valdes CT, Elkind-Hirsch KE (1991) Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocr Metab 72:642–646PubMedCrossRefGoogle Scholar
  39. 39.
    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA (2001) Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia 44:729–737PubMedCrossRefGoogle Scholar
  40. 40.
    Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G (1992) Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (Lond) 453:45–58Google Scholar
  41. 41.
    Wallin BG, Sundlof G (1979) A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects. Hypertension 1:67–77PubMedCrossRefGoogle Scholar
  42. 42.
    Wallin BG, Thompson JM, Jennings GL, Esler MD (1996) Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (Lond) 491:881–887Google Scholar
  43. 43.
    Young CN, Deo SH, Chaudhary K, Thyfault JP, Fadel PJ (2010) Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J Physiol (Lond) 588:3593–3603CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Timothy B. Curry
    • 1
    • 2
  • Casey N. Hines
    • 1
  • Jill N. Barnes
    • 1
    • 2
  • Madhuri Somaraju
    • 1
  • Rita Basu
    • 3
  • John M. Miles
    • 3
  • Michael J. Joyner
    • 1
    • 2
  • Nisha Charkoudian
    • 4
  1. 1.Department of AnesthesiologyMayo ClinicRochesterUSA
  2. 2.Department of Physiology and Biomedical EngineeringMayo ClinicRochesterUSA
  3. 3.Division of EndocrinologyMayo ClinicRochesterUSA
  4. 4.Thermal and Mountain Medicine DivisionUS Army Research Institute of Environmental MedicineNatickUSA

Personalised recommendations